1-1 of 1
Authors: Jeremy Penner
Journal Article
EDITOR'S CHOICE
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial
Clinical Infectious Diseases, Volume 80, Issue 4, 15 April 2025, Pages 889–892, https://doi.org/10.1093/cid/ciae514
Published: 26 November 2024
